The purpose of this study is to determine if people with moyamoya disease who have
insufficient blood flow are at a higher risk for stroke.
Moyamoya disease is a rare medical disorder that affects the blood vessels (pipes that
transport blood) in the brain. In Moyamoya disease, the large blood vessels in the middle
of the brain close down over time. The cause of this disorder is unknown. In order to
compensate for this narrowing, the body grows new small blood vessels around the blockage.
These small branches grow larger (and may be more numerous) to give the disorder its name.
"Moyamoya" is the Japanese term for "puff of smoke" and is used to describe the hazy
appearance of these small blood vessels on an angiogram.
Treatment for moyamoya is difficult because so little is known about the disease. Some
people never have a stroke while others may have several. It is likely that the strokes are
due to insufficient blood flow to the brain. There are surgical procedures that may improve
blood flow to the brain, however, these procedures may cause complications and may not
always improve the blood flow.
The main purpose of this study is to determine if people with moyamoya disease who have
insufficient blood flow are at a higher risk for stroke. In this study researchers will
learn more about the risks and potential benefits of surgical treatment. This information
will help decide if there are people at higher risk for stroke who might benefit from
surgery or if there are those at a lower risk who might not benefit.
In this study, participants will undergo baseline clinical and laboratory evaluation.
Measurements of blood flow to the brain and oxygen use will be obtained using by positron
emission tomography (PET). Participants will be followed for up to 5 years. PET studies
will be conducted one and three years after enrollment to determine if blood flow improves
over time. Participants treated with surgery (at the discretion of their treating
physicians) will also be followed for perioperative complications, improvement in blood
flow, and long term risk of stroke.
- Adult > 18 years of age
- Capable of informed consent
- Clinical: Both asymptomatic and symptomatic patients will be included.
- Anatomic: Unilateral or bilateral imaging findings consistent with moyamoya
collaterals (Suzuki stages 3 and 4) on digital subtraction, computed tomographic, or
magnetic resonance angiography (after Suzuki and Kodama, 1983)
- Any other disease that might be responsible for the vasculopathy, including
atherosclerosis, neurofibromatosis, meningitis, sickle cell disease, skull base
- Pregnancy: All women of child-bearing potential will be tested for pregnancy on the
day of the enrollment and throughout the course of the study.
- Surgery: Prior open or endovascular revascularization procedures, unless there have
been ischemic symptoms since surgery and angiographic evidence that the procedure was